Industry revenues are expected to grow by 20% in the biotechs sector.
3 reports, 1 independent
Updated Aug 31
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Industry revenues are expected to grow by 20% in the biotechs sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CASI Pharmaceuticals (United States)
company in Rockville, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.CASI Pharmaceuticals Second Quarter 2025 Earnings: Misses Expectations Revenue: US$4.18m (up 4.9% from 2Q 2024). Net loss: US$13.4m (loss widened by 92% from 2Q 2024). US$0.86 loss per share (further
- Simply Wall St.MacroGenics Second Quarter 2025 Earnings: Misses Expectations Explore MacroGenics's Fair Values from the Community and select yours Revenue: US$22.2m (up 106% from 2Q 2024). Net loss: US$36.3m (loss
- Simply Wall St.HCW Biologics Second Quarter 2025 Earnings: US$0.90 loss per share (vs US$16.16 loss in 2Q 2024) Explore HCW Biologics's Fair Values from the Community and select yours Net loss: US$1.93m (loss narr